Paul Norwood

5.9k total citations · 2 hit papers
29 papers, 2.9k citations indexed

About

Paul Norwood is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Paul Norwood has authored 29 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Paul Norwood's work include Diabetes Treatment and Management (17 papers), Diabetes Management and Research (14 papers) and Metabolism, Diabetes, and Cancer (10 papers). Paul Norwood is often cited by papers focused on Diabetes Treatment and Management (17 papers), Diabetes Management and Research (14 papers) and Metabolism, Diabetes, and Cancer (10 papers). Paul Norwood collaborates with scholars based in United States, Denmark and United Kingdom. Paul Norwood's co-authors include Richard Pollak, William A. Marston, Jason R. Hanft, Fred T. Fiedorek, Ruth Huh, Ángel Rodríguez, Hiren Patel, Dominik Dahl, Yukiko Onishi and Ross Bray and has published in prestigious journals such as New England Journal of Medicine, JAMA and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Paul Norwood

28 papers receiving 2.8k citations

Hit Papers

The Efficacy and Safety of Dermagraft in Improving the He... 2003 2026 2010 2018 2003 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers
    2003 525 citations Paul Norwood et al. profile →
  2. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes
    2022 387 citations Dominik Dahl, Yukiko Onishi et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Norwood United States 17 2.2k 909 762 446 420 29 2.9k
Lorenzo Scappaticcio Italy 26 1.4k 0.7× 374 0.4× 465 0.6× 30 0.1× 113 0.3× 94 2.1k
Mustafa Kemal Balcı Türkiye 25 931 0.4× 339 0.4× 701 0.9× 61 0.1× 125 0.3× 73 1.9k
Hillary A. Keenan United States 25 1.0k 0.5× 294 0.3× 689 0.9× 36 0.1× 73 0.2× 66 2.0k
Parth Narendran United Kingdom 33 2.2k 1.0× 303 0.3× 1.1k 1.4× 51 0.1× 76 0.2× 145 3.4k
Elisa Giannetta Italy 30 1.5k 0.7× 682 0.8× 452 0.6× 25 0.1× 454 1.1× 84 3.0k
Venkat Vangaveti Australia 20 368 0.2× 246 0.3× 456 0.6× 228 0.5× 52 0.1× 90 1.5k
Leszek Czupryniak Poland 23 732 0.3× 222 0.2× 577 0.8× 94 0.2× 81 0.2× 121 1.9k
Fred W. Whitehouse United States 18 744 0.3× 390 0.4× 373 0.5× 31 0.1× 143 0.3× 56 1.8k
Nikolaos Alexopoulos Greece 26 283 0.1× 311 0.3× 648 0.9× 8 0.0× 90 0.2× 66 2.6k
Adam Gordois United Kingdom 12 496 0.2× 92 0.1× 120 0.2× 221 0.5× 48 0.1× 20 1.2k

Countries citing papers authored by Paul Norwood

Since Specialization
Citations

This map shows the geographic impact of Paul Norwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Norwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Norwood more than expected).

Fields of papers citing papers by Paul Norwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Norwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Norwood. The network helps show where Paul Norwood may publish in the future.

Co-authorship network of co-authors of Paul Norwood

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Norwood. A scholar is included among the top collaborators of Paul Norwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Norwood. Paul Norwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dahl, Dominik, Yukiko Onishi, Paul Norwood, et al.. (2022). Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, is Effective and Safe When Added to Basal Insulin for Treatment of Type 2 Diabetes (SURPASS-5). Diabetologie und Stoffwechsel. 17(S 01). S23–S23.
2.
Dahl, Dominik, Yukiko Onishi, Paul Norwood, et al.. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes. JAMA. 327(6). 534–534. 387 indexed citations breakdown →
3.
Dahl, Dominik, Yukiko Onishi, Paul Norwood, et al.. (2021). 80-LB: Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, Is Effective and Safe When Added to Basal Insulin for Treatment of Type 2 Diabetes (SURPASS-5). Diabetes. 70(Supplement_1). 13 indexed citations
4.
Bode, Bruce W., Satish K. Garg, Paul Norwood, et al.. (2020). Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study. Diabetes Technology & Therapeutics. 23(1). 41–50. 24 indexed citations
5.
Rodbard, Helena W., Ildiko Lingvay, John H. Reed, et al.. (2018). Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 103(6). 2291–2301. 292 indexed citations
6.
7.
8.
Rodbard, Helena W., Ildiko Lingvay, John H. Reed, et al.. (2016). Efficacy and Safety of Semaglutide Once-Weekly vs. Placebo as Add-on to Basal Insulin Alone or in Combination with Metformin in Subjects with Type 2 Diabetes (SUSTAIN 5). Canadian Journal of Diabetes. 40(5). S41–S42. 21 indexed citations
9.
Buse, John B., Federico C. Pérez Manghi, Pedro Alberto García-Hernández, et al.. (2015). 23. Insulin Degludec/Liraglutide (IDegLira) Is Superior to Insulin Glargine (IG) in A1c Reduction, Risk of Hypoglycemia, and Weight Change: DUAL V Study (166-OR). 13(3). 78–79. 6 indexed citations
10.
Dobs, Adrian S., Paul Norwood, Susan Potts, Errol Gould, & Surya Chitra. (2013). Testosterone 2% Gel Can Normalize Testosterone Concentrations in Men with Low Testosterone Regardless of Body Mass Index. The Journal of Sexual Medicine. 11(3). 857–864. 5 indexed citations
11.
Dobs, Adrian S., et al.. (2012). A Novel Testosterone 2% Gel for the Treatment of Hypogonadal Males. Journal of Andrology. 33(4). 601–607. 27 indexed citations
12.
Norwood, Paul, Joanne Liutkus, Harry Haber, et al.. (2012). Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years. Clinical Therapeutics. 34(10). 2082–2090. 22 indexed citations
13.
Liutkus, Joanne, Juan Rosas Guzmán, Paul Norwood, et al.. (2010). A placebo‐controlled trial of exenatide twice‐daily added to thiazolidinediones alone or in combination with metformin. Diabetes Obesity and Metabolism. 12(12). 1058–1065. 68 indexed citations
14.
Riese, Richard J., et al.. (2008). Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes. European Respiratory Journal. 32(1). 180–188. 14 indexed citations
15.
Norwood, Paul. (2007). Inhaled insulin: a clinical perspective with emphasis on EXUBERA®. Expert Review of Endocrinology & Metabolism. 2(3). 313–320. 1 indexed citations
16.
Blakey, Graham, et al.. (2003). Pharmacokinetic and pharmacodynamic assessment of a five‐probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1. British Journal of Clinical Pharmacology. 57(2). 162–169. 58 indexed citations
17.
Gravenstein, Stefan, et al.. (2001). Long‐Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population. Journal of the American Geriatrics Society. 49(8). 1025–1031. 139 indexed citations
18.
Norwood, Paul, et al.. (1997). Skin Abscess with Lumbar Epidural Catheterization in Infants. Anesthesia & Analgesia. 84(6). 1248–1249. 13 indexed citations
19.
Padma-Nathan, Harin, Wayne J.G. Hellstrom, Fran E. Kaiser, et al.. (1997). Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil. New England Journal of Medicine. 336(1). 1–7. 379 indexed citations
20.
Chardot, Christophe, Dominique Debray, Sophie Branchereau, et al.. (1997). Portal vein complications after liver transplantation for biliary atresia. Liver Transplantation and Surgery. 3(4). 351–358. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenzo Scappaticcio Breakdown of academic impact, for papers by Mustafa Kemal Balcı Breakdown of academic impact, for papers by Hillary A. Keenan Breakdown of academic impact, for papers by Parth Narendran Breakdown of academic impact, for papers by Elisa Giannetta Breakdown of academic impact, for papers by Venkat Vangaveti Breakdown of academic impact, for papers by Leszek Czupryniak Breakdown of academic impact, for papers by Fred W. Whitehouse Breakdown of academic impact, for papers by Nikolaos Alexopoulos Breakdown of academic impact, for papers by Adam Gordois
Rankless by CCL
2026